Suppr超能文献

STEP-BD研究中患者的抗抑郁药相关慢性激惹性烦躁不安(ACID)

Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.

作者信息

El-Mallakh Rif S, Ghaemi S Nassir, Sagduyu Kemal, Thase Michael E, Wisniewski Stephen R, Nierenberg Andrew A, Zhang Hong Wei, Pardo Tamara A, Sachs Gary

机构信息

Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, 501 East Broadway, MedCenter One, Suite 340, Louisville, Kentucky 40202, United States.

出版信息

J Affect Disord. 2008 Dec;111(2-3):372-7. doi: 10.1016/j.jad.2008.03.025. Epub 2008 Jun 20.

Abstract

BACKGROUND

It has been proposed that antidepressants can induce a chronic, dysphoric, irritable state in bipolar patients (called ACID for antidepressant-associated chronic irritable dysphoria). This phenomenon has only been described in case series format, and has not been prospectively validated.

METHODS

Prospective data from the first 1500 patients (62.7% with bipolar I, 30.1% with bipolar II, and 7.2% with NOS) treated in the STEP-BD database were examined and those who were euthymic for at least one month at study entry, subsequently developed a depressive episode, and were then followed for one year were identified. Outcome of those who received an antidepressant for this depressive episode (n=27) was compared to those who did not (n=56), with particular attention given to the presence of the proposed symptom triad of ACID, namely dysphoria, irritability, and middle insomnia.

RESULTS

Patients treated with antidepressants were ten times more likely to develop ACID than those who were not (Hazard ratio=9.95, CI=1.103-89.717, P=0.04). However, the hazard ratio dropped to 1.05 (P=0.99) when corrected for significant covariates, notably past antidepressant-related manic switch and sex.

DISCUSSION

This study does not support the existence of ACID as an independent phenomenon. Rather, ACID appears to be part of a broader spectrum of antidepressant treatment-emergent affective switches.

摘要

背景

有人提出抗抑郁药可在双相情感障碍患者中诱发一种慢性、烦躁不安、易怒状态(称为抗抑郁药相关慢性易怒烦躁,即ACID)。这种现象仅以病例系列形式被描述过,尚未得到前瞻性验证。

方法

对STEP - BD数据库中治疗的前1500例患者(62.7%为双相I型,30.1%为双相II型,7.2%为未特定型)的前瞻性数据进行检查,确定那些在研究开始时至少有一个月心境正常、随后出现抑郁发作并随访一年的患者。将因该抑郁发作接受抗抑郁药治疗的患者(n = 27)与未接受抗抑郁药治疗的患者(n = 56)的结果进行比较,特别关注是否存在ACID所提出的症状三联征,即烦躁不安、易怒和中度失眠。

结果

接受抗抑郁药治疗的患者出现ACID的可能性是未接受治疗患者的10倍(风险比 = 9.95,CI = 1.103 - 89.717,P = 0.04)。然而,在校正显著协变量(尤其是既往与抗抑郁药相关的躁狂发作和性别)后,风险比降至1.05(P = 0.99)。

讨论

本研究不支持ACID作为一种独立现象的存在。相反,ACID似乎是更广泛的抗抑郁药治疗引发的情感转换谱的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验